Adempas and Nasacort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Adempas (riociguat) and Nasacort (triamcinolone acetonide). Common drug interactions include dyspnoea among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Adempas and Nasacort. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Adempas?

Adempas has active ingredients of riociguat. eHealthMe is studying from 29,741 Adempas users. Check the latest studies of Adempas.

What is Nasacort?

Nasacort has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 13,298 Nasacort users. Check the latest studies of Nasacort.

On Jul, 19, 2026

15 people who take Adempas and Nasacort together, and have interactions are studied.

What are the common drug interactions of Adempas and Nasacort, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Chest discomfort
Nausea (feeling of having an urge to vomit)
Abdominal distension
Abdominal pain
Agitation (state of anxiety or nervous excitement)
Dizziness
Erythema (redness of the skin)
Fatigue (feeling of tiredness)
Gastrointestinal pain

male:

Cardiac failure congestive
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Malaise (a feeling of general discomfort or uneasiness)
Oedema peripheral (superficial swelling)
Oxygen consumption increased
Oxygen saturation decreased
Peripheral swelling
Pleural effusion (water on the lungs)
Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
Pulmonary oedema (fluid accumulation in the lungs)

What are the common drug interactions of Adempas and Nasacort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal distension
Abdominal pain
Agitation (state of anxiety or nervous excitement)
Chest discomfort
Dizziness
Dyspnoea (difficult or laboured respiration)
Erythema (redness of the skin)
Fatigue (feeling of tiredness)
Gastrointestinal pain
Headache (pain in head)

50-59:

Death

60+:

Dyspnoea (difficult or laboured respiration)
Death
Insomnia (sleeplessness)
Interstitial lung disease
Malaise (a feeling of general discomfort or uneasiness)
Nasal dryness (dry nose)
Oedema peripheral (superficial swelling)
Oxygen consumption increased
Oxygen saturation decreased
Peripheral swelling

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 8 people, 53.33%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 4 people, 26.67%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 20.00%
Sinus Congestion (blockage of sinus): 2 people, 13.33%
Paranasal Sinus Hypersecretion: 2 people, 13.33%
Cough: 2 people, 13.33%
Sinusitis (inflammation of sinus): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Adempas and Nasacort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously